From The Tribune
Center Owned by The Tribune TrustCentre caps trade margin of anti-cancer drugs at 30%; SC asks why not other medicines
RSS excerpt
Finding fault with the Centre’s response on capping the trade margin of anti-cancer drugs at 30% of the maximum retail price (MRP), the Supreme Court on Monday said there was “hardly anything to be happy about” as it wondered why the government could not cap trade margins of other medicines. Faced…